During the past decade, Klinikum Dortmund conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 11 clinical trials were completed, i.e. on average, 39.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Dortmund" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored and "Daiichi Sankyo, Inc." with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Dortmund" #1 collaborator was "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "University of Leipzig" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "AOK PLUS" with 1 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Dortmund" are "Lymphoma" (4 trials), "Ischemic Stroke" (3 trials), "Neuroblastoma" (3 trials), "Depressive Disorder, Major" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Klinikum Dortmund" in a lesser frequency.

Most popular intervention types in "Klinikum Dortmund" are "Drug" (32 trials), "Device" (12 trials), "Biological" (11 trials), "Procedure" (9 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (7 trials), "vincristine sulfate" (7 trials), "radiation therapy" (6 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Dortmund" are 52 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Dortmund". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Klinikum Dortmund, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Dortmund, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 9 trials that are defined as “Not Applicable".

Klinikum Dortmund has several departments that took part in Clinical trials: "Medizinische Klinik Nord" - 2 trials, "Klinikum Dortmund gGmbH, Klinik für Kinder- und Jugendmedizin, Station K1, Abt. Päd. Onkologie / Hämatologie" - 2 trials